WallStSmart
AHCO

Adapthealth Corp

NASDAQ: AHCO · HEALTHCARE · MEDICAL DEVICES

$11.24
+1.64% today

Updated 2026-06-05

Market cap
$1.38B
P/E ratio
P/S ratio
0.42x
EPS (TTM)
$-0.59
Dividend yield
52W range
$8 – $13
Volume
1.4M

Adapthealth Corp (AHCO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2016201720182019202020212022202320242025
Operating cash flow$29.94M$45.93M$68.43M$60.42M$195.63M$275.68M$373.87M$480.67M$541.84M$601.77M
Capital expenditures$2.47M$6.85M$9.95M$21.33M$39.76M$203.31M$391.42M$337.46M$306.06M$382.39M
Depreciation$26.56M$27.82M$50.61M$11.28M$82.44M$258.05M$351.18M$420.59M$365.33M
Stock-based comp$48750.00$48750.00$884000.00$11.07M$18.67M$25.32M$22.40M$22.47M$14.88M$21.88M
Free cash flow$27.47M$39.08M$58.48M$39.09M$155.88M$72.37M$-17.56M$143.20M$235.78M$219.38M
Investing cash flow$-2.68M$-15.08M$-248.87M$-84.87M$-815.70M$-1.82B$-411.17M$-357.28M$-310.27M
Financing cash flow$-27.58M$119820.00$251.33M$-13.89M$643.15M$1.60B$-66.05M$-92.53M$-198.95M
Dividends paid$250.00M$250.00M$250.00M$82.45M$935.94M$3.56M
Share repurchases
Debt repayment
Net change in cash$23.08M$49.66M

Frequently asked questions

What is Adapthealth Corp's revenue?

Adapthealth Corp's trailing twelve-month revenue is $3.29B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is AHCO?

In its most recent fiscal year, AHCO ran a gross margin of 17.52%, an operating margin of 5.74%, and a net margin of -2.18%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does AHCO generate?

AHCO produced $219.38M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is AHCO's balance sheet healthy?

AHCO holds $106.14M in cash and equivalents against $1.72B in long-term debt, on $1.52B of shareholder equity. That debt is best read against the cash flow the business throws off each year.